Amgen

The Race To Treat Stage III Melanoma Just Got A Lot More Interesting
Seeking Alpha
Wed, 12/18/13 - 08:18 am
melanoma
Amgen
Inovio
OncoSec Medical
TVEC
Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
Motley Fool
Tue, 12/17/13 - 10:42 am
Biogen Idec
JNJ
Merck
Bravecto
animal health
Samsung
Hospira
Amgen
AbbVie
anti-TNF
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Yahoo/Fly on the Wall
Tue, 12/17/13 - 09:37 am
Amgen
evolocumab
cholesterol
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
Amgen Announces 2014 First Quarter Dividend
Yahoo/PR NewsWire
Sat, 12/14/13 - 11:42 am
Amgen
Better Earnings: Celgene, Biogen, Or Amgen?
Motley Fool
Fri, 12/6/13 - 08:58 am
Celgene
Biogen Idec
earnings
Amgen
You Call That Efficacy? FDA Warns Amgen For Aranesp Promotion
Pharmalot
Wed, 11/27/13 - 08:51 am
FDA
Amgen
Aranesp
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Forbes
Mon, 11/25/13 - 09:12 am
cholesterol
PCSK9 inhibitors
evolocumab
Amgen
3 New Cholesterol Treatments Worth Watching
Motley Fool
Sun, 11/24/13 - 12:46 pm
Sanofi
Regeneron
Amgen
alirocumab
AMG 145
RN-316
Pfizer
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment
Yahoo/PR NewsWire
Sat, 11/23/13 - 12:06 pm
Nexavar
Bayer
ONYX Pharmaceuticals
Amgen
thyroid cancer
refractory differential thyroid cancer
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thu, 11/21/13 - 11:05 am
Amgen
evolocumab
PCSK9 inhibitors
cholesterol
Talimogene Laherparepvec
Amgen cholesterol drug appears safe, cut LDL 52 pct at 1 year-study
Yahoo/Reuters
Wed, 11/20/13 - 08:31 am
Amgen
cholesterol
asevolocumab
PCSK9 inhibitors
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tue, 11/19/13 - 12:24 pm
Biomarin
Amgen
Merck
AstraZeneca
Amgen presents survival data from Phase 3 study of talimogene laherparepvec
Yahoo/Fly on the Wall
Mon, 11/18/13 - 04:39 pm
Amgen
Talimogene Laherparepvec
melanoma
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Mon, 11/18/13 - 11:07 am
Multiple Myeloma
Amgen
Kyprolis
Celgene
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool
Mon, 11/18/13 - 10:01 am
heart disease
Amgen
statins
Regeneron
Pfizer
Sanofi
PCSK9 inhibitors
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Fri, 11/15/13 - 08:37 am
FDA
cholesterol
PCSK9 inhibitors
statins
Pfizer
Amgen
Sanofi
Regeneron
Watch The R&D Chiefs Of Pfizer, Merck, And Amgen Discuss The Drug Industry's Challenges
Forbes
Thu, 11/14/13 - 10:31 am
R&D
Pfizer
Amgen
Merck
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wed, 11/13/13 - 12:47 pm
cholesterol
statins
PCSK9 inhibitors
Sanofi
Regeneron
Pfizer
Amgen

Pages